T 1330/20 (Microneedle DNA rabies virus vaccine/BOEHRINGER INGELHEIM) of 17.05.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T133020.20220517
- Date of decision
- 17 May 2022
- Case number
- T 1330/20
- Online on
- 21 June 2022
- Petition for review of
- -
- Application number
- 15794751.6
- IPC class
- A61B 5/15A61K 39/12A61B 17/20
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
- Applicant name
- Boehringer Ingelheim Animal Health USA Inc.
Georgia Tech Research Corporation - Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Inventive step - (no)
Inventive step - reasonable expectation of success (yes)
Late-filed request - should have been submitted in first-instance proceedings (yes)
Late-filed evidence - should have been submitted in first-instance proceedings (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.